CA2536069A1 - Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire - Google Patents

Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire Download PDF

Info

Publication number
CA2536069A1
CA2536069A1 CA002536069A CA2536069A CA2536069A1 CA 2536069 A1 CA2536069 A1 CA 2536069A1 CA 002536069 A CA002536069 A CA 002536069A CA 2536069 A CA2536069 A CA 2536069A CA 2536069 A1 CA2536069 A1 CA 2536069A1
Authority
CA
Canada
Prior art keywords
green
therapy
porphyries
effective
green porphyrins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002536069A
Other languages
English (en)
Other versions
CA2536069C (fr
Inventor
Joan W. Miller
Evangelos S. Gragoudas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Eye and Ear
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2536069A1 publication Critical patent/CA2536069A1/fr
Application granted granted Critical
Publication of CA2536069C publication Critical patent/CA2536069C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0036—Porphyrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002536069A 1994-03-14 1994-03-14 Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire Expired - Lifetime CA2536069C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1994/002639 WO1995024930A1 (fr) 1994-03-14 1994-03-14 Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire
CA2185644A CA2185644C (fr) 1994-03-14 1994-03-14 Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA2185644A Division CA2185644C (fr) 1994-03-14 1994-03-14 Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire

Publications (2)

Publication Number Publication Date
CA2536069A1 true CA2536069A1 (fr) 1995-09-21
CA2536069C CA2536069C (fr) 2008-06-03

Family

ID=22242340

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2185644A Expired - Lifetime CA2185644C (fr) 1994-03-14 1994-03-14 Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire
CA002536069A Expired - Lifetime CA2536069C (fr) 1994-03-14 1994-03-14 Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CA2185644A Expired - Lifetime CA2185644C (fr) 1994-03-14 1994-03-14 Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire

Country Status (3)

Country Link
AU (1) AU6813694A (fr)
CA (2) CA2185644C (fr)
WO (1) WO1995024930A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1441743A2 (fr) * 2001-11-09 2004-08-04 Eyetech Pharmaceuticals Procedes destines a traiter des neoformations de vaisseaux sanguins oculaires

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770592A (en) 1991-11-22 1998-06-23 Alcon Laboratories, Inc. Prevention and treatment of ocular neovascularization using angiostatic steroids
JP3845469B2 (ja) * 1996-02-21 2006-11-15 明治製菓株式会社 眼底の新生血管の閉塞に用いる投与剤
US5756541A (en) * 1996-03-11 1998-05-26 Qlt Phototherapeutics Inc Vision through photodynamic therapy of the eye
WO1997035617A1 (fr) * 1996-03-26 1997-10-02 Pharmacyclics, Inc. Utilisation d'une texaphyrine pour le traitement photodynamique des lesions pigmentaires
US6043237A (en) * 1996-12-10 2000-03-28 Qlt Phototherapeutics, Inc. Use of photodynamic therapy for prevention of secondary cataracts
CA2278937A1 (fr) * 1996-12-11 1998-06-18 Pharmacyclics, Inc. Utilisation de texaphyrine dans la preparation d'un medicament employe en diagnostic et therapie oculaires
US6270749B1 (en) 1996-12-11 2001-08-07 Pharmacyclics, Inc. Use of Texaphyrin in ocular diagnosis and therapy
US6022526A (en) * 1997-07-30 2000-02-08 Pharmacyclics, Inc. Use of texaphyrins in detection of melanin and melanin metabolites diagnostic of melanotic melanoma
US6117862A (en) * 1998-10-09 2000-09-12 Qlt, Inc. Model and method for angiogenesis inhibition
IL126953A0 (en) 1998-11-08 1999-09-22 Yeda Res & Dev Pharmaceutical compositions comprising porphyrins and some novel porphyrin derivatives
US6944493B2 (en) 1999-09-10 2005-09-13 Akora, Inc. Indocyanine green (ICG) compositions and related methods of use
US6351663B1 (en) 1999-09-10 2002-02-26 Akorn, Inc. Methods for diagnosing and treating conditions associated with abnormal vasculature using fluorescent dye angiography and dye-enhanced photocoagulation
WO2001017561A1 (fr) * 1999-09-10 2001-03-15 Akorn, Inc. Angiographie a colorants fluorescents et photocoagulation utilisant des colorants
US6443976B1 (en) 1999-11-30 2002-09-03 Akorn, Inc. Methods for treating conditions and illnesses associated with abnormal vasculature
WO2001051087A2 (fr) * 2000-01-12 2001-07-19 Light Sciences Corporation Nouveau traitement pour maladie des yeux
AU2006203034B2 (en) * 2000-02-10 2006-09-07 Massachusetts Eye And Ear Infirmary Methods and compositions for treating conditions of the eye
ATE552855T1 (de) * 2000-02-10 2012-04-15 Massachusetts Eye & Ear Infirm Kombinationen und zubereitung zur anwendung in pdt zur behandlung von augenleiden mit unerwünschter choriodaler neovascularisation
US7753943B2 (en) 2001-02-06 2010-07-13 Qlt Inc. Reduced fluence rate PDT
DE60225783T2 (de) 2001-02-06 2009-04-09 Qlt Inc., Vancouver Photodynamische therapie mit verminderter bestrahlungsstärke
US6723750B2 (en) 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
CA2500877A1 (fr) 2002-10-03 2004-04-15 Light Sciences Corporation Systeme et procede d'excitation d'elements photosensibles des tissus de l'oeil

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171749A (en) * 1987-01-20 1992-12-15 University Of British Columbia Wavelength-specific cytotoxic agents
US5214036A (en) * 1990-03-08 1993-05-25 University Of British Columbia Benzoporphyrin derivatives for photodynamic therapy

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1441743A2 (fr) * 2001-11-09 2004-08-04 Eyetech Pharmaceuticals Procedes destines a traiter des neoformations de vaisseaux sanguins oculaires
EP1441743A4 (fr) * 2001-11-09 2009-02-25 Eyetech Pharmaceuticals Procedes destines a traiter des neoformations de vaisseaux sanguins oculaires

Also Published As

Publication number Publication date
CA2185644A1 (fr) 1995-09-21
WO1995024930A1 (fr) 1995-09-21
AU6813694A (en) 1995-10-03
CA2185644C (fr) 2011-04-12
CA2536069C (fr) 2008-06-03

Similar Documents

Publication Publication Date Title
CA2536069A1 (fr) Utilisation de prophyrines vertes pour le diagnostic et la therapie oculaire
CA2248087A1 (fr) Vision amelioree par therapie photodynamique de l'oeil
CA2245066A1 (fr) Zincophtalocyanines et conjugues correspondants; methode pour les preparer et leur emploi comme agents phototherapeutiques et photodiagnostiques
CA2087902A1 (fr) Compositions liposomiques renfermant des photosensibilisateurs a base de porphyrine
WO2001039764A3 (fr) Methodes de traitement de troubles et de maladies associes a une anomalie du systeme vasculaire
CA2287262A1 (fr) Colorants de synthese labiles aux acides et clivables par voie enzymatique pour le diagnostic avec de la lumiere dans le proche infrarouge et pour l'usage therapeutique
CA2269698A1 (fr) Agent therapeutique contre les troubles neurodegeneratifs
AU1916995A (en) 4-amino derivatives of mycophenolic acid with immunosuppressant activity
CA2406650A1 (fr) Agents de diagnostic cationique, d'imagerie et de therapie associes a des sites vasculaires actives
AU1875495A (en) 5-substituted derivatives of mycophenolic acid
WO2003057259A3 (fr) Compositions de vert d'indocyanine et procedes d'utilisation correspondants
CA2437563A1 (fr) Therapie photodynamique de degenerescence maculaire occulte liee a l'age
CA2273010A1 (fr) Utilisation de porphyrines vertes pour preparer un medicament servant a traiter les cataractes secondaires
IE801655L (en) Indoles.
IE791235L (en) Acyl-derivatives of carnitine.
IL130246A0 (en) Use of a texaphyrin in the preparation of a medicament for use in ocular diagnosis and therapy
WO1998039293A3 (fr) 13-thia prostaglandines destinees a etre utilisees dans la therapie du glaucome
ATE183774T1 (de) Löslicher interferon-rezeptor, seine herstellung und anwendung
CA2347863A1 (fr) Traitement des affections de la retine
ATE298339T1 (de) ß3,7-DIAZABICYCLO(3.3.0)OCTANE UND DEREN VERWENDUNG BEI DER BEHANDLUNG VON HERZRHYTHMUSSTÖRUNGENß
DE69808921T2 (de) 4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOL-1-ACETAMID-DERIVATE, IHRE HERSTELLUNG UND THERAPEUTISCHE ANWENDUNG
CA2298820A1 (fr) Utilisation de 1,3,4,6-tetrahydroxy-helianthrone et de ses derives dans le traitement photodynamique et certains nouveaux derives
MXPA02003522A (es) Derivados de rodamina para diagnostico fotodinamico y tratamiento.
CA2353527A1 (fr) Utilisation de stimulateurs des facteurs neurotrophiques pour le traitement des affections neurodegeneratives ophtalmiques
ATE210126T1 (de) 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20140314